WORLD'S LARGEST MARKET RESEARCH RESOURCE — 1,519,265 REPORTS

 
 
• SEARCH FOR A REPORT

Viewing report

Search
Enter keywords, a title or a report id number below.
Advanced

• ORDER BY FAX

Order By Fax

• SELECT SITE CURRENCY

Select a currency for use throughout the site



  • Electronic (PDF) Information Icon
  • Site License Information Icon
  • Enterprisewide Information Icon
Live Chat Live Help Software for Website

InVivoScribe Technologies, Inc. - Product Pipeline Analysis

GlobalData, November 2011, Pages: 16

InVivoScribe Technologies, Inc. - Product Pipeline Analysis

Summary

InVivoScribe Technologies, Inc. (InVivoScribe) is a biotechnology company engaged in providing tools for molecular diagnostics, hematopathology, and complementary DNA synthesis. InVivoScribe provides a comprehensive selection of PCR-based gene rearrangement, chromosome translocation, and gene mutation testing reagents and controls. Its products are used to identify, stratify and monitor leukemias, lymphomas and other lymphoproliferative diseases. The company's LabPMM is a CLIA- and CAP accredited reference laboratory, which is located in San Diego. LabPMM is the only reference lab outside Japan licensed to perform FLT3 and NPM1 biomarker testing. In addition, it is also developing a comprehensive ERP software solution. InVivoScribe launched its first fully integrated business package on February 1st 2010. Further, it is expected that a commercial package will be available to the customers by the end of 2010. The company provides research and in vitro diagnostic products in more than 50 countries around the world. The products offered by the company are certified with CE mark. InVivoScribe is headquartered in California, the US.

This report is a source for data, analysis and actionable intelligence on the InVivoScribe Technologies, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.
- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.



List of Tables
List of Figures
Key Facts
InVivoScribe Technologies, Inc. - Major Products and Services
InVivoScribe Technologies, Inc. Pipeline Products by Equipment Type
InVivoScribe Technologies, Inc. Pipeline Products by Development Stage
InVivoScribe Technologies, Inc. Pipeline Products by Therapy Area
BCL1/JH Translocation Assay - Gel Detection
Product Status
Product Description
BCL2/JH t(14;18) Translocation Assay - Gel Detection
Product Status
Product Description
BCL2/JH Translocation Assay - Gel Detection
Product Status
Product Description
BCR/ABL t(9;22) Translocation Assay - Gel Detection
Product Status
Product Description
FLT3 Biomarker - Acute Myeloid Leukemia
Product Status
Product Description
IGH Somatic Hypermutation Assay V2.0
Product Status
Product Description
PML/RARa t(15;17) Translocation Assay
Product Status
Product Description
InVivoScribe Technologies, Inc. - Key Competitors
InVivoScribe Technologies, Inc. - Key Employees
InVivoScribe Technologies, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
InVivoScribe Technologies, Inc., Key Facts
InVivoScribe Technologies, Inc. Key Pipeline Products by Equipment Type
InVivoScribe Technologies, Inc. Key Pipeline Products by Therapy Area
InVivoScribe Technologies, Inc. Key Pipeline Products by Development Stage
InVivoScribe Technologies, Inc., Key Facts
InVivoScribe Technologies, Inc., Major Products and Services
InVivoScribe Technologies, Inc. Number of Pipeline Products by Equipment Type
InVivoScribe Technologies, Inc. Pipeline Products by Equipment Type
InVivoScribe Technologies, Inc. Number of Pipeline Products by Development Stage
InVivoScribe Technologies, Inc. Pipeline Products by Development Stage
InVivoScribe Technologies, Inc. Number of Pipeline Products by Therapy Area
InVivoScribe Technologies, Inc. Pipeline Products by Therapy Area
BCL1/JH Translocation Assay - Gel Detection - Product Status
BCL1/JH Translocation Assay - Gel Detection - Product Description
BCL2/JH t(14;18) Translocation Assay - Gel Detection - Product Status
BCL2/JH t(14;18) Translocation Assay - Gel Detection - Product Description
BCL2/JH Translocation Assay - Gel Detection - Product Status
BCL2/JH Translocation Assay - Gel Detection - Product Description
BCR/ABL t(9;22) Translocation Assay - Gel Detection - Product Status
BCR/ABL t(9;22) Translocation Assay - Gel Detection - Product Description
FLT3 Biomarker - Acute Myeloid Leukemia - Product Status
FLT3 Biomarker - Acute Myeloid Leukemia - Product Description
IGH Somatic Hypermutation Assay V2.0 - Product Status
IGH Somatic Hypermutation Assay V2.0 - Product Description
PML/RARa t(15;17) Translocation Assay - Product Status
PML/RARa t(15;17) Translocation Assay - Product Description
InVivoScribe Technologies, Inc., Key Employees
InVivoScribe Technologies, Inc., Other Locations

List of Figures
InVivoScribe Technologies, Inc. Key Pipeline Products by Equipment Type
InVivoScribe Technologies, Inc. Pipeline Products by Equipment Type
InVivoScribe Technologies, Inc. Pipeline Products by Development Stage
InVivoScribe Technologies, Inc. Pipeline Products by Therapy Area

New England Biolabs, Inc.
Efficas, Inc.
Cannabis Science, Inc.
BioNeutral Group, Inc.
Catalent Pharma Solutions, Inc.

Customers who bought this item also bought